MBX Biosciences, Inc. (MBX)
NASDAQ: MBX · Real-Time Price · USD
11.14
+0.03 (0.27%)
At close: May 12, 2025, 4:00 PM
11.14
0.00 (0.00%)
After-hours: May 12, 2025, 4:05 PM EDT
MBX Biosciences Market Cap
MBX Biosciences has a market cap or net worth of $372.35 million as of May 12, 2025.
Market Cap
372.35M
Enterprise Value
110.37M
1-Year Change
n/a
Ranking
Category
Stock Price
11.14
Market Cap Chart
Since the IPO on September 13, 2024, MBX Biosciences's market cap has decreased from $509.66M to $372.35M, a decrease of -26.94%. That is a compound annual growth rate of -38.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 371.34M | -39.71% |
| Dec 31, 2024 | 615.88M | 20.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.56B |
| Johnson & Johnson | 369.81B |
| UnitedHealth Group | 349.88B |
| AbbVie | 330.64B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 230.65B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |